Skip to main content
SpringerLink
Log in

Disorders of haemostasis in diabetes mellitus

  • Editorials
  • Published:
Ricerca in clinica e in laboratorio

Summary

The frequent occurrence of vascular complications in diabetes mellitus has prompted extensive research into possible mechanisms which may relate to these complications. Recently, most emphasis has been directed towards the platelet and there is now good evidence of disordered platelet function, platelet biochemistry and platelet vessel wall interaction in many diabetic patients. In addition to these disturbances of platelet behaviour, other haemostatic abnormalities are not uncommon in the diabetic patient. These include evidence of coagulation activation, impaired fibrinolysis and altered blood viscosity. All of these changes could theoretically predispose to a thrombotic state, but the precise relationship between the observed abnormalities and the development and progression of the vascular complications remains to be established.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abrahamsen A. F.: Platelet survival studies in man, with special reference to thrombosis and atherosclerosis — Scand. J. Haemat.5 (Suppl.), 3, 1968.

    Google Scholar 

  2. Almer L.-O., Nilsson I. M.: On fibrinolysis in diabetes mellitus — Acta med. scand.198, 101, 1975.

    PubMed  CAS  Google Scholar 

  3. Almer L.-O., Pandolfi M., Nilsson I. M.: Diabetic retinopathy and the fibrinolytic system — Diabetes24, 529, 1975.

    Article  PubMed  CAS  Google Scholar 

  4. Barnes A. J.: Blood viscosity in diabetes mellitus. In:Lowe G. D. O., Barbenel J. C., Forbes C. D. (Eds): Clinical aspects of blood viscosity and cell deformability. Springer-Verlag, Berlin-Heidelberg-New York, 1981; p. 151.

    Google Scholar 

  5. Bedi H. K., Vyas B. R., Bomb B. S., Agarwal M. L., Bedi T.: Fibrinogen content and fibrinolytic activity of blood in diabetics before and after antidiabetic drugs — J. Ass. Phycns India25, 181, 1977.

    CAS  Google Scholar 

  6. Begg G. S., Pepper D. S., Chesterman C. N., Morgan F. J.: Complete covalent structure of human β-thromboglobulin — Biochemistry17, 1739, 1978.

    Article  PubMed  CAS  Google Scholar 

  7. Bensoussan D., Levy-Toledano S., Passa P., Caen J., Canivet J.: Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy — Diabetologia11, 307, 1975.

    Article  PubMed  CAS  Google Scholar 

  8. Bern M. M.: Platelet functions in diabetes mellitus — Diabetes27, 342, 1978.

    PubMed  CAS  Google Scholar 

  9. Best L. C., Jones P. B., Preston F. E.: Effect of glucose on platelet thromboxane biosynthesis — Lancetii, 790, 1979.

    Article  Google Scholar 

  10. Bridges J. M., Dalby A. M., Millar J. H., Weaver J. A.: An effect of D-glucose on platelet stickiness — Lanceti, 75, 1965.

    Article  Google Scholar 

  11. Burrows A. W., Chavin S. I., Hockaday T. D.: Plasma thromboglobulin concentrations in diabetes mellitus — Lanceti, 235, 1978.

    Article  Google Scholar 

  12. Butkus A., Skrinska V. A., Schumacher O. P.: Thromboxane production and platelet aggregation in diabetic subjects with clinical complications — Thrombos. Res.19, 211, 1980.

    Article  CAS  Google Scholar 

  13. Campbell I. W., Dawes J., Fraser D. M., Pepper D. S., Clarke B. F., Duncan L. J., Cash J. D.: Plasma beta-thromboglobulin in diabetes mellitus — Diabetes26, 1175, 1977.

    Article  PubMed  CAS  Google Scholar 

  14. Coller B. S., Frank R. N., Milton R. C., Gralnick H. R.: Plasma cofactors of platelet function: correlation with diabetic retinopathy and haemoglobins\(A_{1_{a \cdot c} } \) — Ann. intern. Med.88, 311, 1978.

    PubMed  CAS  Google Scholar 

  15. Colwell J. A., Halushka P. V., Sarji K. E., Lopes-Virella M. F., Sagel J.: Vascular complications in diabetes — Arch. intern. Med.139, 225, 1979.

    Article  PubMed  CAS  Google Scholar 

  16. Cooper R. A.: Abnormalities of cell-membrane fluidity in the pathogenesis of disease — New Engl. J. Med.297, 371, 1977.

    PubMed  CAS  Google Scholar 

  17. Corbella E., Miragliotta G., Masperi R., Villa S., Bini A., de Gaetano G., Chiumello G.: Platelet aggregation and antithrombin III levels in diabetic children — Haemostasis8, 30, 1979.

    PubMed  CAS  Google Scholar 

  18. Creter D., Pavlotzky F., Savir H.: Platelet aggregation in diabetic retinopathy — Acta haemat. (Basel)60, 53, 1978.

    CAS  Google Scholar 

  19. Crofford D. B.: Report of the National Commission on Diabetes. The long-range plan to combat diabetes. NIH publication no. 76-1018, US Department of Health, Education and Welfare. Public Health Service National Institute of Health, 1976; vol. 1.

  20. Dassin E., Najean Y., Poirier O., Passa P., Bensoussan D.:In vivo platelet kinetics in 31 diabetic patients. Correlation with the degree of vascular impairment — Thrombos. Haemost.40, 83, 1978.

    CAS  Google Scholar 

  21. Davis T. M., Bown E., Finch D. R., Mitchell M. D., Turner R. C.:In vitro venous prostacyclin production, plasma 6-keto-prostaglandin F1α concentrations and diabetic retinopathy — Brit. med. J.282, 1259, 1981.

    CAS  Google Scholar 

  22. Davis T. M., Mitchell M. D., Turner R. C.: Prostacyclin and thromboxane metabolites in diabetes — Lancetii, 789, 1979.

    Article  Google Scholar 

  23. Dawes J., Borsey D. Q., Fraser D. M., Prowse C. V., Elton R. A., Clarke B. F.: Plasma beta-thromboglobulin in diabetes mellitus — Diabetologia18, 353, 1980.

    PubMed  Google Scholar 

  24. Dintenfass L.: Blood viscosity factors in severe non-diabetic and diabetic retinopathy — Biorheology14, 151, 1977.

    PubMed  CAS  Google Scholar 

  25. Dollery C. T., Friedman L. A., Hensby C. N., Kohner E., Lewis P. J., Porta M., Webster J.: Circulating prostacyclin may be reduced in diabetes — Lancetii, 1365, 1979.

    Article  Google Scholar 

  26. Editorial: Platelets, beta-thromboglobulin and diabetes mellitus — Lanceti, 250, 1978.

    Google Scholar 

  27. Egeberg O.: The blood coagulability in diabetic patients — Scand. J. clin. Lab. Invest.15, 533, 1963.

    Article  PubMed  CAS  Google Scholar 

  28. Fagerberg S. E.: Diabetic neuropathy, a clinical and histological study on the significance of vascular affections — Acta med. scand.164 (Suppl. 345), 1, 1959.

    Google Scholar 

  29. Ferguson J. C., Mackay N., Philip J. A.: Determination of platelet and fibrinogen half-life with (75 Se) selenomethionine: studies in normal and diabetic subjects — Clin. Sci. molec. Med.49, 115, 1975.

    CAS  Google Scholar 

  30. Fuller J. H., Keen H., Jarrett R. J., Omer T., Meade T. W., Chakrabarti R., North W. R., Stirling Y.: Haemostatic variables associated with diabetes and its complications — Brit. med. J.ii, 964, 1979.

    Google Scholar 

  31. Fuster V., Bowie E. J. W., Lewis J. C., Fass D. N., Owen C. A.: Resistance to arteriosclerosis in pigs with von Willebrand’s disease. Spontaneous and high cholesterol diet-induced — J. clin. Invest.61, 722, 1978.

    Article  PubMed  CAS  Google Scholar 

  32. Gensini G. F., Abbate R., Favilla S., Neri Serneri G. G.: Changes of platelet function and blood clotting in diabetes mellitus — Thrombos. Haemost.42, 983, 1979.

    CAS  Google Scholar 

  33. Graves J. M., Colwell J. A., Nair R. M. G., Sarji K. E.: The effect of oral glucose on von Willebrand factor activity in normal and diabetic subjects — Clin. Endocr.6, 437, 1977.

    Article  PubMed  CAS  Google Scholar 

  34. Greaves M., Preston F. E.: Plasma 6-keto prostaglandin F1α, fact or fiction — Thrombos. Res. (In press).

  35. Halushka P. V., Rogers R. C., Loadholt C. B., Colwell J. A.: Increased platelet thromboxane synthesis in diabetes mellitus — J. Lab. clin. Med.97, 87, 1981.

    PubMed  CAS  Google Scholar 

  36. Hamberg M., Svensson J., Samuelsson B.: Thromboxanes; a new group of biologically active compounds derived from prostaglandin endoperoxides — Proc. nat. Acad. Sci. (Wash.)72, 2994, 1975.

    Article  CAS  Google Scholar 

  37. Harrison H. E., Reece A. H., Johnson M.: Effect of insulin treatment on prostacyclin in experimental diabetes — Diabetologia18, 65, 1980.

    Article  PubMed  CAS  Google Scholar 

  38. Hassanein A. A., El-Garf T. A., El-Baz A.: Platelet aggregation in diabetes mellitus and the effect of insulinin vivo on aggregation — Thrombos. Diathes. haemorrh. (Stuttg.)27, 114, 1972.

    CAS  Google Scholar 

  39. Heath H., Brigden W. D., Canever J. V., Pollock J., Hunter P. R., Kelsey J., Bloom A.: Platelet adhesion and aggregation in relation to diabetic retinopathy — Diabetologia7, 308, 1971.

    Article  PubMed  CAS  Google Scholar 

  40. Hockaday T. D. R.: Direct animal and indirect human evidence of altered platelet function in diabetics — Mctabolism28, 415, 1979.

    CAS  Google Scholar 

  41. Honour A. J., Hockaday T. D. R.: Increased sensitivity ofin vivo platelet aggregation in rabbits after alloxan or streptozotocin — Brit. J. exp. Path.57, i, 1976.

    Google Scholar 

  42. Jones R. L., Peterson C. M.: Reduced fibrinogen survival in diabetes mellitus: a reversible phenomenon — J. clin. Invest.63, 485, 1979.

    Article  PubMed  CAS  Google Scholar 

  43. Kelsey J., Bloom A.: Platelet adhesion and aggregation in relation to diabetic retinopathy — Diabetologia7, 308, 1971.

    Article  PubMed  Google Scholar 

  44. Khosla P. K., Mahabaleswara M., Tiwari H. K., Saraya A. K.: Platelet aggregation and retinal microangiopathy in diabetes and hypertension — Acta haemat. (Basel)61, 161, 1979.

    Article  CAS  Google Scholar 

  45. Kwaan H. C., Colwell J. A., Cruz S., Suwanwela N., Dobbie J. G.: Increased platelet aggregation in diabetes mellitus — J. Lab. clin. Med.80, 236, 1972.

    PubMed  CAS  Google Scholar 

  46. Lecrubier C., Scarabin P. Y., Grauso F., Samama M.: Platelet aggregation related to age in diabetes mellitus — Haemostasis9, 43, 1980.

    PubMed  CAS  Google Scholar 

  47. Lufkin E. G., Fass D. N., O’Fallon W. M., Bowie E. J.: Increased von Willebrand factor in diabetes mellitus — Metabolism28, 63, 1979.

    Article  PubMed  CAS  Google Scholar 

  48. McMillan D. E.: Disturbance of serum viscosity in diabetes mellitus — J. clin. Invest.53, 1071, 1974.

    Article  PubMed  CAS  Google Scholar 

  49. McMillan D. E., Utterback N. G., La Puma J.: Reduced erythrocyte deformability in diabetes — Diabetes27, 895, 1978.

    PubMed  CAS  Google Scholar 

  50. Malmsten C.: Prostaglandins, thromboxanes and platelets — Brit. J. Haemat.41, 453, 1979.

    Article  PubMed  CAS  Google Scholar 

  51. Mayne E. E., Bridges J. M., Weaver J. A.: Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitus — Diabetologia6, 436, 1970.

    Article  PubMed  CAS  Google Scholar 

  52. Meade T. W., North W. R., Chakrabarti R., Stirling Y., Haines A. P., Thompson S. G., Brozovic M.: Haemostatic function and cardiovascular death: early results of a prospective study — Lanceti, 1050, 1980.

    Article  Google Scholar 

  53. Moncada S., Gryglewski R., Bunting S., Vane J. R.: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation — Nature (Lond.)263, 663, 1976.

    Article  CAS  Google Scholar 

  54. Moncada S., Vane J. R.: Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls — New Engl. J. Med.300, 1142, 1979.

    PubMed  CAS  Google Scholar 

  55. Needleman P., Minkes M., Raz A.: Thromboxanes: selective biosynthesis and distinct biological properties — Science193, 163, 1976.

    Article  PubMed  CAS  Google Scholar 

  56. O’Malley B. C., Ward J. D., Timperley W. R., Porter N. R., Preston F. E.: Platelet abnormalities in diabetic peripheral neuropathy — Lancetii, 1274, 1975.

    Article  Google Scholar 

  57. Oppenheimer E. H., Esterly J. R.: Thrombosis in the newborn: comparison between infants of diabetic and non-diabetic mothers — J. Pediat.67, 549, 1965.

    Article  PubMed  CAS  Google Scholar 

  58. Pepper D. S., Ludlam C. A.: β-thromboglobulin — a new approach to the diagnosis of thrombosis. In:Mills D. C. B., Pareti F. I. (Eds): Platelets and thrombosis. Serono Symposium no. 10, London. Academic Press, New York, 1977; p. 145.

    Google Scholar 

  59. Peterson C. M., Jones R. L., Koenig R. J., Melvin E. T., Lehrman M. L.: Reversible haematologic sequelae of diabetes mellitus — Ann. intern. Med.86, 425, 1977.

    PubMed  CAS  Google Scholar 

  60. Preston F. E., Ward J. D., Marcola B. H., Porter N. R., Timperley W. R., O’Malley B. C.: Elevated β-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy — Lanceti, 238, 1978.

    Article  Google Scholar 

  61. Sagel J.: Platelet adhesion and aggregation in diabetes mellitus — Metabolism28, 394, 1979.

    Article  PubMed  Google Scholar 

  62. Sagel J., Colwell J. A., Crook L., Laimins M.: Increased platelet aggregation in early diabetes mellitus — Ann. intern. Med.82, 733, 1975.

    PubMed  CAS  Google Scholar 

  63. Sarji K. E., Nair R. M. G., Schraibman H. B., Chambers A. L., Laimins M., Barnes M., Colwell J. A.: Relation between growth hormone and von Willebrand factor activity — Circulation52, 144, 1975.

    Google Scholar 

  64. Schmid-Schönbein H., Volger E.: Red cell aggregation and red cell deformability in diabetes — Diabetes25 (Suppl. 2), 897, 1976.

    PubMed  Google Scholar 

  65. Silberbauer K., Schernthaner G., Sinzinger H., Piza-Katzer H., Winter M.: Decreased vascular prostacyclin in juvenile-onset diabetes — New Engl. J. Med.300, 366, 1979.

    PubMed  CAS  Google Scholar 

  66. Smith J. B., Ingerman G. B., Silver M. J.: Effects of arachidonic acid and some of its metabolites on platelets. In:Silver M. J., Smith J. B., Kocas J. J. (Eds): Prostaglandins in haematology. Spectrum, New York, 1977.

    Google Scholar 

  67. Stuart M. J., Elrad H., Graeber J. E., Hakanson D. O., Sunderji S. G., Barvinchak M. K.: Increased synthesis of prostaglandin endoperoxides and platelet hyperfunction in infants of mothers with diabetes mellitus — J. Lab. clin. Med.94, 12, 1979.

    PubMed  CAS  Google Scholar 

  68. Takeuchi A., Benirschke K.: Renal vein thrombosis of the newborn and its relation to maternal diabetes — Biol. Neonat. (Basel)3, 237, 1961.

    CAS  Google Scholar 

  69. Timperley W. R., Preston F. E., Ward J. D.: Cerebral intravascular coagulation in diabetic ketoacidosis — Lanceti, 952, 1974.

    Article  Google Scholar 

  70. Timperley W. R., Ward J. D., Preston F. E., Duckworth T., O’Malley B. C.: A reassessment of vascular factors in relation to intravascular coagulation — Diabetologia12, 237, 1976.

    Article  PubMed  CAS  Google Scholar 

  71. Tindall H., Paton R. C., Zuzel M., McNicol G. P.: Platelet life-span in diabetics with and without retinopathy — Thrombos. Res.21, 641, 1981.

    Article  CAS  Google Scholar 

  72. Weiss H. J., Lages B. A.: Possible congenital defect in platelet thromboxane synthetase — Lanceti, 760, 1977.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, The University of Sheffield Royal Hallamshire Hospital, Glossop Road, S10 2JF, Sheffield, Great Britain

    Francis E. Preston

Authors
  1. Francis E. Preston
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preston, F.E. Disorders of haemostasis in diabetes mellitus. La Ricerca Clin. Lab. 12, 425–438 (1982). https://doi.org/10.1007/BF02909394

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02909394

Key-words

Search

Navigation